BBS-Bioactive Bone Substitutes Oyj reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was EUR 3.09 million compared to EUR 2.77 million a year ago. Basic loss per share from continuing operations was EUR 0.38 compared to EUR 0.42 a year ago.
BBS-Bioactive Bone Substitutes Oyj
Equities
BONEH
FI4000260583
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.393 EUR | -0.25% | +2.88% | -19.63% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.63% | 8.21M | |
+8.29% | 124B | |
-5.61% | 11.02B | |
+4.83% | 8.88B | |
+39.60% | 5.45B | |
-22.04% | 4.74B | |
+8.39% | 3.44B | |
-6.28% | 2.84B | |
-10.23% | 2.15B | |
-5.99% | 2.11B |
- Stock Market
- Equities
- BONEH Stock
- News BBS-Bioactive Bone Substitutes Oyj
- BBS-Bioactive Bone Substitutes Oyj Reports Earnings Results for the Full Year Ended December 31, 2022